A2 MILK

A2 Milk recorded a net profit attributable to shareholders for the year ended 30 June 2026 that fell 44% to NZ$113.6m, after which the share price dropped 10.2% to NZ$7.39. The profit slump was driven by a 14% decline in infant formula sales in China to NZ$544.3m, caused by supply‑chain disruptions after unusually strong demand in the third quarter, production bottlenecks and higher freight costs that squeezed margins. The disappointment contrasts with earlier half‑year performance and an increased full‑year forecast; however, analysts had already been more cautious. The restrictive monetary policy of the RBNZ is also weighing on growth‑oriented consumer stocks across the market, and heavy dependence on China remains a structural risk for A2 Milk. » Más en de.investing.com

A2 Milk warned of shortages of China-label infant milk formula and downgraded its fiscal 2026 sales and profit outlook, cutting its EBITDA margin estimate to 14–14.5%. The company cited strong demand, global recalls, added cereulide testing and border inspections, higher air-freight needs tied to the Middle East conflict, and a Synlait production backlog as drivers of in-market supply shortfalls. A2 expects material product availability impacts in April–May 2026 and said English-label products are less exposed; shares fell about 12–13% on the news. » Más en finance.yahoo.com